SCOTTSDALE, Ariz.—West Pharmaceutical Services Inc. has added two clean rooms and a laboratory at its plant in Scottsdale to support increased manufacturing of new product lines.
About 32,000 square feet of existing space at the 65,000-sq.-ft. pharmaceutical delivery systems engineering center was converted to create the Class 10,000 clean rooms, lab and an area for additional warehousing, according to Tom McLean, West executive director of engineering and site manager.
The ISO 7 clean rooms replaced an ISO 8 room and a “white” manufacturing room. The new microbiology lab was built in unused space, he said, and the warehousing section takes over an area that was used to produce tooling.
Cost of the expansion wasn't released.
West undertook the project “to provide the necessary manufacturing environment and support required for new West products, such as the Daikyo Crystal Zenith 1mL long insert needle syringe, cartridges and new delivery systems, such as the ConfiDose auto- injector platform technology and SmartDose electronic patch injector platform technology,” McLean said.
The company has a five-year business plan that includes significant additional investment in manufacturing to support West's drug delivery system products as they are commercialized, including Crystal Zenith syringes, he said.
As the demand for those goods grows, which the firm anticipates, “West expects to add staff to support the manufacturing operation,” McLean said. As many as 100 jobs could be added over the next five years. The firm didn't specify what the investments will cover.
Headquartered in Lionville, Pa., West employs 580—with 97 of them based at the Scottsdale site—at its four plants in Arizona, which operate under the Tech Group name. West has 32 manufacturing sites and 34 sales facilities globally. It makes consumer, health care and medical devices at the Scottsdale location.
The primary line of products currently being manufactured by West at the facility—the Daikyo Crystal Zenith syringe system—is made of a cyclic olefin polymer developed by Daikyo Seiko Ltd., which licensed the technology to West, according to Scott Young, senior director for Daikyo Crystal Zenith.
“With the expansion, we hope to leverage the skills and experience of the Scottsdale engineering team to develop and manufacture West's new product lines,” McLean said. “This team has a successful record of developing and commercializing drug delivery systems for customers through the Tech Group business unit.”
Daikyo manufactures other Crystal Zenith products that West sells, Young said. Those include ready-to-use vials, syringes and containers, which are sterilized and distributed by West.
West's working relationship with Daikyo “is very collaborative and adaptive,” he said, adding that “we will deploy the best resources in our collective capability to serve the customer.”
He said the Daikyo Crystal Zenith prefillable syringe system can help keep packaged drugs pure by cutting exposure to extractables and silicone oil, which minimizes potential leachables in the drug product; reduces the risk of protein aggregation caused by silicone oil; provides consistent release and travel force; reduces absorption; and helps eliminate several issues related to glass containers.
West took over the Scottsdale facility in 2005 when it acquired Tech Group, for which it served as a headquarters, contract manufacturing and the central development engineering center.